"Research presented at ENDO 2026 indicates that prenatal and postnatal exposure to DEHP causes lasting anxiety in male rats. The study suggests potential behavioral risks for humans exposed to endocrine-disrupting chemicals during development. GABA agonists and testosterone treatments were found to reverse the anxiety-related behavioral changes in the subjects."